95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind ...

Scientists are building autonomous robotic labs powered by artificial intelligence. The goal, they say, is for these robots ...

The Department of Transportation is revising a requirement that it calls an “inadvertent factual impossibility” from its drug testing procedures. A provision from DOT’s 2023 oral fluid drug testing ...

Andrei Georgescu, PhD, CEO of Vivodyne, was hoping to couple his interests in science and engineering when he chose UPenn for his graduate research. His goal was to build on his background in ...

Many promising therapies fail because preclinical models do not fully capture the complexity of the human heart. A new review ...